FMS
Fresenius Medical Care AG
Services-Misc Health & Allied Services, NEC
Fresenius Medical Care (FMS) Stock: Buy, Sell, or Hold?
$22.22
-0.52 (-2.29%)
âŧ
5d:
-4.18%
30d:
+5.41%
90d:
-5.97%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (71%)
Quality Score
46/100
Position
FAIR
30-Day Fair Range
$21.42 â $22.98
Position: FAIR
Forward P/E & Valuation
9.3x
STRETCHED
vs 7.2x historical avg
Wall Street Target
$22.36
+0.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$21.46 / $23.83
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: FMS is fairly priced but lacks strong directional signals. At 8.8% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Get Alerted When FMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.13
Based on 0.0% avg growth
INTRINSIC VALUE TODAY
$10.64
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FMS is currently trading at $22.22, which is considered fair relative to its 30-day fair value range of $21.42 to $22.98. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.3) compared to its historical average (7.2). At these levels, the market is pricing in 8.8% annual earnings growth.
Technical Outlook: Technically, FMS is in a downtrend. Immediate support is located at $21.46, while resistance sits at $23.83.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FMS is in a downtrend. Immediate support is located at $21.46, while resistance sits at $23.83.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$21.42 -
$22.98
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
Trading Range & Key Levels
30-Day Trading Range
$21.42 -
$22.98
Current vs Trading Range
FAIR
Support Level
$21.46
Resistance Level
$23.83
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($22.36)
- BULLISH: Expecting earnings turnaround to 8.8% growth with 1.1% revenue growth
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
9.32
Wall Street Target
$22.36
(+0.6%)
Revenue Growth (YoY)
1.1%
Earnings Growth (YoY)
-35.4%
Profit Margin
4.2%
Valuation Premium vs History
+8.8% premium
PE vs Historical
9.3 vs 7.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.8%
(market-implied from PE analysis)
1-Year Target
$24.18
(+9%)
2-Year Target
$26.30
(+18%)
3-Year Target
$28.62
(+29%)
3-Yr Target (if PE normalizes)
(PE: 9â7)
PE COMPRESSION
$22.11
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -4.0%)
$41.88
(+89%)
Base:
(SPY PE: 9.3, Growth: -4.0%)
$19.65
(-12%)
Bear:
(PE: 7.2, Growth: -4.0%)
$15.18
(-32%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 13.14 | Current EPS (TTM): $1.73
Bull Case
$34.48
(+55%)
Analyst growth 37.8%, PE expands to 14.5
Base Case
$31.34
(+41%)
Market implied 37.8%, PE stable at 13.1
Bear Case
$15.46
(-30%)
Severe decline -20.0%, PE contracts to 11.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share FMS Analysis
Share this live FMS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (FMS)
Bullish
1 Retail Mentions
Reddit / WSB Comments
1
Bullish
Last Tracked
Aug 21, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on FMS are bullish (sentiment score +0.40) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
Data refreshes hourly during market hours. Next update: 8:52 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FMS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
23 analysts |
$306 | 50 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 34 SELL |
|
CON
Concentra Group HoldingsâĻ |
STRONG BUY
11 analysts |
$44 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$156 | 36 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive FMS Research Pages
